Skip to main content
Back to Norwest

Norwest's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by Norwest. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$472.0M

Pharmaceutical Portfolio Companies (5)

Export
BiotechnologyPharmaceuticalTherapeutics

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

Redwood City, United States
June 2025
$80.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CarePharmaceutical

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Waltham, United States
March 2026
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareLife ScienceMedicalPharmaceutical

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

San Diego, United States
March 2024
$167.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Seattle, United States
July 2025
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.

Austin, United States
October 2023
$25.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Explore Norwest's Full Portfolio

View all companies funded by Norwest across every industry and funding stage.

View Full Norwest Portfolio